We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > BioAegis Therapeutics

News List

BioAegis Therapeutics Initiates Trial of Its Inflammation Regulator for COVID-19 Treatment americanpharmaceuticalreview
August 07, 2020
BioAegis Therapeutics enrolled its first patient in its Phase 2 study of hospitalized patients with severe COVID-19 pneumonia.
BioAegis Therapeutics receives approval to proceed with phase 2 trial of its gelsolin Covid-19 treatment pharmaceutical-business-review
July 21, 2020
BioAegis Therapeutics Inc., announces that it received regulatory clearance from The Spanish Agency for Medicines and Health Products (AEMPS) for its Phase 2 Proof of Concept study of its lead product, recombinant human plasma gelsolin (rhu-pGSN) in ...